
Sobre este pódcast
Your daily pharmaceutical news briefing — FDA decisions, clinical trial results, biotech M&A, and drug pipeline updates in under 15 minutes, every weekday. Hosted by Alex Mercer and Maya Patel. Plus a Week in Review every Sunday synthesizing the week's biggest moves in pharma and biotech. Covering drug approvals, licensing and M&A deals, biopharma investing, and healthcare market intelligence. Smart, fast, and built for pharma and biotech professionals who need to stay ahead.…
146 episodios · Ciencias de la vida
The Pharma Closeout | Daily Pharmaceutical and Biotech News in 15 Minutes
Sobre este pódcast
Your daily pharmaceutical news briefing — FDA decisions, clinical trial results, biotech M&A, and drug pipeline updates in under 15 minutes, every weekday. Hosted by Alex Mercer and Maya Patel. Plus a Week in Review every Sunday synthesizing the week's biggest moves in pharma and biotech. Covering drug approvals, licensing and M&A deals, biopharma investing, and healthcare market intelligence. Smart, fast, and built for pharma and biotech professionals who need to stay ahead.…
Episodios recientes
- Week in Review | Revita Slows Regain After Tirzepatide at Six Months; Liquidia Settles With United Therapeutics19 oct · 46 min
- Daily Roundup | Enspryng Approved for Thyroid Eye Disease as Home Injection & Omeros Refused Again by EU Panel17 oct · 12 min
- Daily Roundup | Anktiva Expands Bladder Cancer Label & Vanda's Anxiety Trial Misses16 oct · 14 min
- Daily Roundup | BioNTech's Cancer Trial Setback & Roche's Fat-Cell Bet15 oct · 13 min
- Daily Roundup | Bristol's Split IPF Result & RYZ101's Phase 3 Win13 oct · 13 min
- Week in Review | AstraZeneca's $2B Summit Bet, Merck's Eye Trial & Roche's Vamikibart Filing12 oct · 44 min
- MDS 2026 Debrief: Two Genetic Bets Fall in Full Data & Juvmo Meets Its Payers12 oct · 16 min
- Daily Roundup | Hovilpri Wins FDA Approval & Biohaven Licenses BHV-1300 to Ono for $80M at Closing10 oct · 8 min
- Daily Roundup | Tecentriq Approved After dMMR Colon Cancer Surgery & Zenbexus Topline: Median PFS 42 vs 20 Months9 oct · 10 min
- Daily Roundup | Pfizer Adds a Breast Cancer Maintenance Choice & MimiVax's Brain Cancer Vaccine Misses8 oct · 8 min